CAR-T growing up with big pharma’s big bet – BioPharma Dive
|
CAR–T growing up with big pharma's big bet
BioPharma Dive In the span of just five months, Gilead Sciences Inc. and Celgene Corp. — both large-cap biotechs with long-term growth worries — each made major bets on the potential of cancer cell therapies. With two of the three largest biotech deals in the last … |
